Co Optical

Washington State University, $5,000

Co Optical is developing a novel, non-invasive and continuous blood glucose monitoring device to aid in management of type II diabetes. The device, structured as a pair of glasses, will non-invasively record the electrical signals present in the skin around the eyes. These signals, which correspond to the blood glucose level of the person, will be interpreted by the device.


By continuing to use the site, you agree to the use of cookies. Read More

By continuing to use the site, you agree to the use of cookies. Read More